ResearcherScientific Centre of MonacoNo recent work listed
Christopher Montemagno
Matched on ORCID iD 0000-0002-5687-1812; OpenAlex author ID A5053641516.
Their work
- Papers
- 3 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Collaborators
- 3
2019: 1 paper · 2020: 1 paper · 2021: 1 paper
Papers 3
- Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine? First author DOI 10.3390/ijms22126413↗
- From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/ijms21114067↗
- 99mTc-A1 as a Novel Imaging Agent Targeting Mesothelin-Expressing Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/cancers11101531↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Gilles Pagès · 3 shared papers, 2019–2021
- Paper Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine? DOI 10.3390/ijms22126413↗
- Paper From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/ijms21114067↗
- Paper 99mTc-A1 as a Novel Imaging Agent Targeting Mesothelin-Expressing Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers11101531↗
- Jacques Pouysségur · 2 shared papers, 2019–2020
- Cathérine Ghezzi · 1 shared paper, 2019
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.